BTIG Initiates Cartesian Therapeutics(RNAC.US) With Buy Rating, Announces Target Price $42

Futu NewsDec 21 02:43 · Ratings

Revenues Not Telling The Story For Cartesian Therapeutics, Inc. (NASDAQ:RNAC)

Simply Wall StDec 18 21:04

Cartesian Therapeutics Announces New Employment Inducement Grants

GlobeNewswireDec 18 20:05

Cartesian Therapeutics Files For Proposed Resale Or Other Disposition By Selling Stockholders Of Up To 6.3M Common Stock

BenzingaDec 14 05:18

Express News | Cartesian Therapeutics Files for Mixed Shelf Offering of up to $400 Mln - SEC Filing

BreakingsDec 14 05:08

Cartesian Therapeutics Insider Sold Shares Worth $345,134, According to a Recent SEC Filing

MT NewswiresDec 12 05:31